Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

scientific article

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.3310/HTA14110
P698PubMed publication ID20223123
P5875ResearchGate publication ID41909474

P2093author name stringA Greene
E Cummins
N Waugh
P Royle
L McIntyre
L Robertson
A Snaith
P433issue11
P921main subjectsystematic reviewQ1504425
cost-effectiveness analysisQ1754768
preproinsulinQ7240673
P304page(s)iii-iv, xi-xvi, 1-181
P577publication date2010-02-01
P1433published inHealth Technology AssessmentQ15708880
P1476titleClinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
P478volume14

Reverse relations

cites work (P2860)
Q45406346'The pump was a saviour for me.' Patients' experiences of insulin pump therapy
Q88312423A Comparative Pulse Accuracy Study of Two Commercially Available Patch Insulin Infusion Pumps
Q92318301A cost of illness study evaluating the burden of Wolfram syndrome in the United Kingdom
Q63977503A longitudinal study of fear of hypoglycaemia in adults with type 1 diabetes
Q31146468A multicentre randomized controlled trial of an empowerment-inspired intervention for adolescents starting continuous subcutaneous insulin infusion--a study protocol.
Q28076381An Overview of Insulin Pumps and Glucose Sensors for the Generalist
Q38548147Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications
Q44702806Benefits of continuous subcutaneous insulin infusion on quality of life
Q38502143Care of diabetes in children and adolescents: controversies, changes, and consensus
Q37275651Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
Q38652925Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons
Q64079119Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation
Q35627208Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review
Q98195623Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis
Q55332090Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE)
Q90049585Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security
Q45017464Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000.
Q36597980Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments
Q28689671Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
Q37054720Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress.
Q36130870Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines
Q90210722Drugs to Control Diabetes During Pregnancy
Q53553958Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
Q46793013Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study.
Q38265052Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia
Q37972355How technology has changed diabetes management and what it has failed to achieve
Q37015613Impact of insulin pump on quality of life of diabetic patients.
Q37288564Influences on Technology Use and Efficacy in Type 1 Diabetes
Q47721261Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes
Q38037730Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion
Q38205861Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems
Q48068782Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents
Q59476028Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen
Q37988797Management of diabetes mellitus: is the pump mightier than the pen?
Q38580509Multiple Daily Injections OR Insulin Pump Therapy: Choosing the Best Option for Your Patient-An Evidence-based Approach.
Q37315361Novel Insulin Delivery Technologies in Women with Pregestational Type 1 Diabetes: A Review of the Literature
Q44302852Parents' emotional intelligence and children's type I diabetes management
Q38154208Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy
Q37796716Preconception care for women with diabetes and prevention of major congenital malformations
Q90115679Pregnancy outcomes among women with type 1 diabetes mellitus using continuous subcutaneous insulin infusion versus multiple daily injections: A retrospective cohort study
Q48673138Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE).
Q33598549Service usage and vascular complications in young adults with type 1 diabetes
Q37403943Short-term effects of continuous subcutaneous insulin infusion therapy in perioperative patients with diabetes mellitus
Q38137278Site of initial diabetes education does not affect metabolic outcomes in children with T1DM.
Q91678179Stressful Life Events in Young Adults With Type 1 Diabetes in the U.S. T1D Exchange Clinic Registry
Q35538888Study protocol for a randomised controlled trial of insulin delivery by continuous subcutaneous infusion compared to multiple daily injections
Q38121007Systematic review of drug administration costs and implications for biopharmaceutical manufacturing
Q89578870The Development and Psychometric Validation of the Diabetes Impact and Device Satisfaction Scale for Individuals with Type 1 Diabetes
Q34151785The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial
Q30409804The evidence base for diabetes technology: appropriate and inappropriate meta-analysis
Q93002593The influence of demographic, social-educational determinants and diabetes management on agreement between glucometer and logbook and its impact on glycemic control in patients with type 1 diabetes: a follow-up study
Q38725717The rise of technology in diabetes care. Not all that is new is necessarily better
Q37781158Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems
Q61816913Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Q40653348Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial

Search more.